<DOC>
	<DOC>NCT01543204</DOC>
	<brief_summary>This study will evaluate the efficacy of etanercept in patients with plaque psoriasis who have lost a satisfactory response to adalimumab.</brief_summary>
	<brief_title>Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Moderate to severe plaque psoriasis Loss of satisfactory response to adalimumab Currently receiving or recently discontinued treatment with adalimumab Active skin conditions that would interfere with evaluations of the effect of investigational product on psoriasis Serious medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>plaque psoriasis</keyword>
	<keyword>etanercept</keyword>
	<keyword>adalimumab</keyword>
</DOC>